BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38200519)

  • 21. Intercellular adhesion molecule 2 as a novel prospective tumor suppressor induced by ERG promotes ubiquitination-mediated radixin degradation to inhibit gastric cancer tumorigenicity and metastasis.
    Tang X; Huang J; Jiang Y; Qiu J; Li T; Li W; Chen Z; Huang Z; Yu X; Yang T; Ji X; Tan R; Lv L; Yang Z; Chen H
    J Transl Med; 2023 Sep; 21(1):670. PubMed ID: 37759298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
    Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
    Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
    Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
    Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
    J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.
    De Schutter J; Guillabert A; Imbault V; Degraef C; Erneux C; Communi D; Pirson I
    J Biol Chem; 2009 Dec; 284(52):36062-36076. PubMed ID: 19880507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
    Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
    Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
    Huang S; Jin A
    J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PHB2 promotes tumorigenesis
    Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
    Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
    [No Abstract]   [Full Text] [Related]  

  • 30. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
    Tao Y; Sun C; Zhang T; Song Y
    Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.
    Li Q; Ge Y; Chen X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    J Cell Biochem; 2019 Sep; 120(9):15190-15201. PubMed ID: 31021450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis.
    He J; Yi J; Ji L; Dai L; Chen Y; Xue W
    Mol Med; 2024 May; 30(1):69. PubMed ID: 38783226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1.
    Zhang N; Gao X; Yuan Q; Fu X; Wang P; Cai F; Liu H; Zhang J; Liang H; Nie Y; Deng J
    Clin Epigenetics; 2023 May; 15(1):77. PubMed ID: 37147733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
    Hu J; Wang M; Yang Y; Xing Y; Li S
    Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
    [No Abstract]   [Full Text] [Related]  

  • 35. NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling.
    Zhang Y; Goodfellow R; Li Y; Yang S; Winters CJ; Thiel KW; Leslie KK; Yang B
    Gynecol Oncol; 2015 Oct; 139(1):127-33. PubMed ID: 26193427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hsa_circ_0023409 Accelerates Gastric Cancer Cell Growth and Metastasis Through Regulating the IRS4/PI3K/AKT Pathway.
    Li J; Yang Y; Xu D; Cao L
    Cell Transplant; 2021; 30():963689720975390. PubMed ID: 33439739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
    Liu X; Long Z; Cai H; Yu S; Wu J
    Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
    [No Abstract]   [Full Text] [Related]  

  • 38. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
    Zhang C; Lin X; Zhao Q; Wang Y; Jiang F; Ji C; Li Y; Gao J; Li J; Shen L
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):329-342. PubMed ID: 31912229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation.
    Yu S; Chen C; Chen M; Liang J; Jiang K; Lou B; Lu J; Zhu X; Zhou D
    J Exp Clin Cancer Res; 2024 Jan; 43(1):32. PubMed ID: 38268030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.